The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Deirdre WeymannJanessa LaskinRobyn RoscoeKasmintan A SchraderStephen ChiaStephen YipWinson Y CheungKaren A GelmonAly KarsanDaniel J RenoufMarco MarraDean A Regier

Published in: Molecular genetics & genomic medicine (2017)

WGA costs decreased over the studied time horizon, but expenditures needed to realize WGA remain significant. Future research exploring costs and benefits of WGA-guided cancer care are crucial to guide health policy.

Keyphrases

public health
healthcare
mental health
current status
health information
risk assessment
young adults
replacement therapy